What is the recommended initial psychiatric evaluation and treatment plan for an adult presenting with both attention‑deficit/hyperactivity disorder (ADHD) and generalized anxiety disorder (GAD)?

Initial Psychiatric Evaluation and Treatment for Adult ADHD with Comorbid Anxiety

For adults presenting with both ADHD and anxiety, proceed with a stimulant trial first unless the anxiety is severe, and the comorbid anxiety does not preclude stimulant use—in fact, stimulants remain effective and well-tolerated in this population. 1

Initial Psychiatric Evaluation

The evaluation must establish childhood onset of ADHD symptoms and rule out conditions that mimic ADHD. Here's what to assess:

Core ADHD Assessment

• Childhood symptom onset: ADHD symptoms must have been present before age 7 (per DSM-IV criteria referenced in guidelines). Obtain detailed developmental history focusing on inattention, hyperactivity, and impulsivity from early childhood 1
• Collateral information: Interview a spouse, parent, or significant other—adults with ADHD notoriously underestimate their symptom severity and functional impairment 1
• Structured rating scales: Use validated instruments including:
  • Wender Parent's Rating Scale
  • Wender Utah Rating Scales
  • Brown Attention-Deficit Disorder Scale for Adults
  • Conners Adult ADHD Rating Scale 1

Substance Use Screening

Critical caveat: Given the high comorbidity of substance abuse with ADHD, obtain a detailed drug and alcohol history and consider urine drug screening before prescribing stimulants 1

Differential Diagnosis to Rule Out

• Bipolar disorder
• Major depressive disorder
• Personality disorders (especially borderline and antisocial)
• Learning disabilities
• Narcolepsy
• Borderline intellectual functioning 1

Medical Evaluation

• Complete medical history and physical examination
• Screening laboratory tests to exclude medical conditions mimicking ADHD 1
• Assess for cardiac symptoms before initiating stimulants 2

Anxiety Assessment

• Determine severity of anxiety symptoms
• Assess for specific anxiety disorder diagnoses (GAD, social phobia, panic disorder)
• Evaluate functional impairment from anxiety versus ADHD 1

Treatment Algorithm

When Anxiety is NOT Severe or Primary

Start with a stimulant trial. This is the guideline-recommended approach because:

1. Stimulants work rapidly, allowing quick assessment of ADHD symptom response 1
2. Reduction in ADHD-related morbidity often substantially improves anxiety symptoms as a secondary effect 1
3. Evidence shows stimulants are effective in comorbid ADHD-anxiety, contrary to older concerns about reduced response 1

Stimulant dosing for adults 1:

• Methylphenidate (MPH): 5-20 mg three times daily, titrate to total daily dose of approximately 1 mg/kg
• Dexamphetamine (DEX): 5 mg three times daily to 20 mg twice daily

Post-Stimulant Trial Assessment

After establishing adequate stimulant dosing:

• If both ADHD and anxiety symptoms remit: Continue stimulant monotherapy 1
• If ADHD improves but anxiety remains problematic:
  • First pursue psychosocial intervention for anxiety (cognitive behavioral therapy or interpersonal therapy) 1
  • If anxiety doesn't respond to psychotherapy or is severe, add an SSRI to the stimulant 1

When Anxiety IS Severe or Primary

If anxiety presents with severe symptoms (psychosis, suicidality, or severe functional impairment), treat the anxiety first 1. However, this represents a minority of cases. One case series suggests treating anxiety until clear symptom reduction occurs before addressing ADHD may be more appropriate than treating ADHD alone 3.

Important Clinical Considerations

Evidence Nuances

The guidelines explicitly state that ADHD with comorbid generalized anxiety disorder and social phobia may be treated with stimulants 1. More recent data from the MTA study showed that patients with ADHD and comorbid anxiety actually had greater treatment response differences compared to those without anxiety, contradicting earlier concerns 1.

Monitoring Requirements

• Physical: Cardiac symptoms, appetite changes, sleep disturbances, seizures 2
• Psychiatric: Mood disturbances, anxiety exacerbation, psychosis, insomnia 1
• Common side effects include loss of appetite, insomnia, and anxiety—but these are generally well-tolerated 1

Alternative Medications

• Atomoxetine: Non-stimulant option with demonstrated benefit in comorbid ADHD-anxiety, requires careful side effect monitoring 4
• Bupropion: Second-line agent for ADHD, has antidepressant properties but limited evidence for treating both conditions simultaneously 1

Psychotherapy Integration

Cognitive behavioral therapy targeting both ADHD-related executive dysfunction and anxiety symptoms should be integrated into treatment, particularly when anxiety symptoms persist despite adequate ADHD treatment 5, 6, 7